Brittany Schlater dominated the 2024 CPU Canadian National Championships and unofficially broke the Raw Deadlift IPF World ...

A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...

Boehringer Ingelheim’s investigational compound nerandomilast, which targets the PDE4B enzyme involved in fibrosis and ...

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.

On Saturday, September 21, the Ivy Pearl Foundation (IPF) will hold its 25th Anniversary celebration at the YWCA ...

Living with IPF has brought many emotional ups and downs for columnist Sam Kirton, and recent events have caused him to hit ...

Luca Richeldi, MD, PhD, outlined crucial lessons from recent idiopathic pulmonary fibrosis (IPF) trial failures, advocating ...

FIRST COLLABORATIVE EFFORT UNDER NEW AGREEMENT ALLEN, TX / ACCESSWIRE / September 18, 2024 / (OTC PINK:ENZC) ("enzolytics.com ...